Literature DB >> 32772256

Maternal and fetal vitamin D and their roles in mineral homeostasis and fetal bone development.

B A Ryan1, C S Kovacs2.   

Abstract

During pregnancy, female physiology adapts to meet the additional mineral demands of the developing fetus. Meanwhile, the fetus actively transports minerals across the placenta and maintains high circulating levels to mineralize the rapidly developing skeleton. Most of this mineral is accreted during the last trimester, including 30 g of calcium, 20 g of phosphate and 0.8 g of magnesium. Given the dependence of calcium homeostasis on vitamin D and calcitriol in the adult and child, it may be expected that vitamin D sufficiency would be even more critical during pregnancy and fetal development. However, the pregnant mother and fetus appear to meet their mineral needs independent of vitamin D. Adaptations in maternal mineral and bone metabolism during pregnancy appear to be invoked independent of maternal vitamin D, while fetal mineral metabolism and skeletal development appear to be protected from vitamin D deficiency and genetic disorders of vitamin D physiology. This review discusses key data from both animal models and human studies to address our current knowledge on the role of vitamin D and calcitriol during pregnancy and fetal development.

Entities:  

Keywords:  Calcitriol; Calcium; Fetus; Intestinal calcium absorption; Mineralization; Phosphate; Pregnancy; Skeleton; Vitamin D

Year:  2020        PMID: 32772256     DOI: 10.1007/s40618-020-01387-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  104 in total

1.  Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation.

Authors:  Janine P Woodrow; Christopher J Sharpe; Neva J Fudge; Ana O Hoff; Robert F Gagel; Christopher S Kovacs
Journal:  Endocrinology       Date:  2006-05-04       Impact factor: 4.736

2.  Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnover.

Authors:  G N Kent; R I Price; D H Gutteridge; J R Allen; S L Blakeman; C I Bhagat; A St John; M P Barnes; M Smith; D V Evans
Journal:  Miner Electrolyte Metab       Date:  1991

3.  Calcium metabolism in normal human pregnancy.

Authors:  R P Heaney; T G Skillman
Journal:  J Clin Endocrinol Metab       Date:  1971-10       Impact factor: 5.958

4.  Absence of Calcitriol Causes Increased Lactational Bone Loss and Lower Milk Calcium but Does Not Impair Post-lactation Bone Recovery in Cyp27b1 Null Mice.

Authors:  Brittany R Gillies; Brittany A Ryan; Brett A Tonkin; Ingrid J Poulton; Yue Ma; Beth J Kirby; René St-Arnaud; Natalie A Sims; Christopher S Kovacs
Journal:  J Bone Miner Res       Date:  2017-08-02       Impact factor: 6.741

5.  Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study.

Authors:  N A Cross; L S Hillman; S H Allen; G F Krause; N E Vieira
Journal:  Am J Clin Nutr       Date:  1995-03       Impact factor: 7.045

6.  Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor.

Authors:  Neva J Fudge; Christopher S Kovacs
Journal:  Endocrinology       Date:  2010-01-05       Impact factor: 4.736

7.  Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies.

Authors:  Curtiss D Hunt; Luann K Johnson
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

Review 8.  Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.

Authors:  Christopher S Kovacs
Journal:  Physiol Rev       Date:  2016-04       Impact factor: 37.312

Review 9.  Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones.

Authors:  Christopher S Kovacs
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

10.  Skeletal recovery after weaning does not require PTHrP.

Authors:  Beth J Kirby; Laleh Ardeshirpour; Janine P Woodrow; John J Wysolmerski; Natalie A Sims; Andrew C Karaplis; Christopher S Kovacs
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

View more
  4 in total

1.  Vitamin D Levels in Pregnant Women Do Not Affect Neonatal Bone Strength.

Authors:  Orly Levkovitz; Elena Lagerev; Sofia Bauer-Rusak; Ita Litmanovitz; Eynit Grinblatt; Gisela Laura Sirota; Shachar Shalit; Shmuel Arnon
Journal:  Children (Basel)       Date:  2022-06-13

2.  Total 25(OH)D Concentration Moderates the Association between Caffeine Consumption and the Alkaline Phosphatase Level in Pregnant Women.

Authors:  Keith T S Tung; Rosa S Wong; Calvin K M Cheung; Jennifer K Y Ko; Bianca N K Chan; Albert Lee; Hung-Kwan So; Wilfred H S Wong; Wing-Cheong Leung; Patrick Ip
Journal:  Nutrients       Date:  2022-04-13       Impact factor: 6.706

3.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

4.  Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.

Authors:  Jakob Höppner; Sabrina Lais; Claudia Roll; Andreas Wegener-Panzer; Dagmar Wieczorek; Wolfgang Högler; Corinna Grasemann
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.